With several products currently in the clinic and a long-term vision for our future, Facet Biotech is a small but sophisticated biotechnology company focused on research, discovery, innovation and development. Using a disciplined, sophisticated, biology-driven approach, our company is dedicated to advancing our current pipeline of four clinical-stage products and leveraging our research and development capabilities to identify and develop new drugs. We are passionate and committed about the... More >>

Recent News

More >>

02/02/10 - 4:31 p.m. Facet Biotech to Present at 12th Annual Bio CEO & Investor Conference

01/11/10 - 8:35 a.m. Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma

12/17/09 - 9:21 a.m. Facet Biotech Stockholders Reject Biogen Idec Tender Offer

Upcoming Events

More >>

Date Title 02/09/10 8:30 a.m. ET FACET BIOTECH CORP at Biotechnology Industry Organization CEO & Investor Conference Location New York, NY

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Facet Biotech Corporation posts new information to the site. Just enter your e-mail address and click Submit.

Contact Information

Investor Relations Phone: 650-454-1508 Fax: 650-454-1488 E-mail: Investor.Relations@facetbiotech.com

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.